# I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy

> **NCT00362037** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 281 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Irbesartan (Aprovel)

## Key facts

- **NCT ID:** NCT00362037
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2011-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362037, "I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00362037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*